Resalis Therapeutics
Resalis Therapeutics changes the way metabolic diseases are treated by targeting a key regulator of pathways that contribute to obesity and fatty liver disease. RES-010, the company's flagship program, is being developed using its expertise in non-coding RNA drug modality and lipid metabolism to provide a safe and convenient treatment option with disease-modifying therapeutic effects, such as long-term weight loss and reduced hepatic steatosis. Resalis is rapidly moving RES-010 into clinical trials for a variety of metabolic disorders, backed by strong preclinical evidence.
Tech Stack (10 technologies)
Frequently Asked Questions
What technologies does Resalis Therapeutics use?+
Resalis Therapeutics uses 10 technologies including WordPress, CookieYes, jQuery.
What industry is Resalis Therapeutics in?+
Resalis Therapeutics operates in the Biotechnology industry.
Where is Resalis Therapeutics based?+
Resalis Therapeutics is headquartered in Italy.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026